A yearly injection such as Lenacapavir could help overcome barriers to PrEP accessibility by increasing its uptake and making ...
Patients who struggle to take daily HIV pills can benefit from long-acting injectable treatments, a new study has found.
New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly ...
Every year, my colleagues and I put together a list of what we think are the top 10 breakthrough technologies of that year.
Your FREE insider update on the biggest news stories and investing trends, delivered midday TheChart of the Day belongs to ...